Loading clinical trials...
Loading clinical trials...
The Purpose of the Study is to Compare the Efficacy and Safety of BMS-986489 (Anti-fucosyl-GM1+ Nivolumab Fixed Dose Combination) in Combination with Carboplatin plus Etoposide to that of Atezolizumab...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
First line of the email MUST contain NCT # and Site #.
CONTACT
Lead Sponsor
Bristol-Myers Squibb
NCT07390565 · Extensive-stage Small Cell Lung Cancer (SCLC)
NCT04397003 · Extensive-stage Small Cell Lung Cancer
NCT06748495 · Extensive-stage Small Cell Lung Cancer (ES-SCLC)
NCT07328490 · Extensive-Stage Small Cell Lung Cancer, Extrapulmonary Neuroendocrine Carcinoma, and more
NCT04373369 · Extensive-stage Small Cell Lung Cancer
Southern Cancer Center, PC
Daphne, Alabama
Local Institution - 0283
Hot Springs, Arkansas
Florida Cancer Specialists - South
Fort Myers, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions